Assess whether working capital should be a walk-away (5fb588)

SITUATION Carve-out separation lead is responsible for working capital should be in a PE platform evaluating a founder-led SaaS add-on, using regulatory-approval critical-path calendar as the only working extract. An HSR second-request rumor is what reset the timeline for this M&A Due Diligence Separation and Integration file.

DECISION Carve-out separation lead in a PE platform evaluating a founder-led SaaS add-on must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after an HSR second-request rumor.

HYPOTHESES TO TEST 1. Carve-out separation lead can defend Proceed from regulatory-approval critical-path calendar after an HSR second-request rumor in a M&A Due Diligence challenge. 2. Carve-out separation lead cannot defend Proceed from regulatory-approval critical-path calendar; Reprice is what the extract actually supports after an HSR second-request rumor. 3. An HSR second-request rumor never reached the population in regulatory-approval critical-path calendar — reopen intake, do not close working capital should be. 4. Two facts in regulatory-approval critical-path calendar after an HSR second-request rumor conflict for carve-out separation lead; hold this Separation and Integration file.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 2. Map reps, earnout mechanics, and integration risk a PE platform evaluating a founder-led SaaS add-on would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to working capital should be. 4. For this M&A Due Diligence Separation and Integration file, read regulatory-approval critical-path calendar against an HSR second-request rumor and write the one fact that would move working capital should be for carve-out separation lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Separation and Integration packet (regulatory-approval critical-path calendar after an HSR second-request rumor). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after an HSR second-request rumor, then the two facts that force it, then the Monday action for carve-out separation lead in a PE platform evaluating a founder-led SaaS add-on.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on working capital should be, then the evidence in regulatory-approval critical-path calendar, then the action for carve-out separation lead - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - What changes working capital should be if an HSR second-request rumor is later withdrawn - Named option among Proceed, Reprice, Walk and the fact that kills the others